Lixa
PrivateLast Round
VC Round
Jun 5, 2025
Total Funding Raised
$1.53M
Company Overview
Lixa operates in Healthcare & Life Sciences and is based in Nedlands. Its latest recorded funding round was a Grant round in August 2024.
Lixa is a biotechnology company that develops small-molecule resistance modulators designed to dismantle bacterial biofilms and restore the effectiveness of existing antimicrobial treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lixa Comparables
Compare Lixa with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Disperazol Pharma ApS | 79% | |
| BioTryp Therapeutics | 78% | |
| Microbion Corporation | 74% |
For institutional investors. Book with your work email.
Lixa Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 5, 2025 | ||||
| Grant | Aug 16, 2024 | ||||
| Seed | Sep 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lixa Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Industries and Innovation Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 681% MoM.
- Dec 26, 2025
Grew 23% QoQ, from 13 to 16 employees.
For institutional investors. Book with your work email.
Lixa Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lixa's valuation, stock price, and market status.
Is Lixa a public or private company?
Lixa is a private company.
What is the current stock price of Lixa?
Lixa is a private company, so its shares have no public market price. Caplight tracks Lixa's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lixa worth (valuation)?
Valuation information for Lixa is not publicly available.
Can I buy Lixa stock?
Lixa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lixa's last funding round?
Lixa's most recent funding round was VC Round on June 5, 2025.
Who are the main investors in Lixa?
Key investors in Lixa include New Industries and Innovation Fund.
Will Lixa IPO soon?
No public IPO plans have been announced for Lixa.
How can I track Lixa secondary market activity?
Caplight tracks bids, offers, and trades in Lixa's shares on secondary markets.